Исследования
Образование
Решения
RU
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Войдите в систему
Oncology R&D group
Jonathon Golas has not added Biography.
If you are Jonathon Golas and would like to personalize this page please email our Author Liaison for assistance.
Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth.
Oncotarget Feb, 2015 | Pubmed ID: 25671303
Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.
Proceedings of the National Academy of Sciences of the United States of America 12, 2018 | Pubmed ID: 30487219
Pfizer Worldwide Research and Development
Shuang Chen1,
Andreas Giannakou1,
Jonathon Golas1,
Kenneth G. Geles1
1Oncology R&D group, Pfizer Worldwide Research and Development
Конфиденциальность
Условия эксплуатации
Политика
СВЯЖИТЕСЬ С НАМИ
РЕКОМЕНДОВАТЬ БИБЛИОТЕКЕ
НОВОСТИ JoVE
JoVE Journal
Подборки методов
JoVE Encyclopedia of Experiments
Архив
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
АВТОРЫ
Библиотекарь
Доступ
О JoVE
JoVE Sitemap
Авторские права © 2025 MyJoVE Corporation. Все права защищены
